NCT06052917 DECIdE, Shared DECIsion in hEalth : the Real-life Impact Study
| NCT ID | NCT06052917 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Clermont-Ferrand |
| Condition | Decision Making, Shared |
| Study Type | INTERVENTIONAL |
| Enrollment | 288 participants |
| Start Date | 2024-05-05 |
| Primary Completion | 2025-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 288 participants in total. It began in 2024-05-05 with a primary completion date of 2025-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the DECIdE study is to evaluate the effect of a decision aid (the DECIdE tool) for shared decision making concerning optional prescription drugs on the level of uncertainty-certainty or comfort-inconfort (= decisional conflict) experienced by patients, compared with a condition of routine care without the use of a decision aid. General practitionners and pharmacists will propose to their patients, complaining of a common symptom for which a drug is usually prescribed or dispensed, to discuss this drug and the symptom in order to reach a shared decision on whether to take it or choose another alternative.
Eligibility Criteria
Inclusion Criteria: * Patients over 18 consulting a general practitioner or community pharmacy * Patient complaining of a symptom or requesting a optional prescription drug (clinical situations and medicines pre-defined by expert consensus) * First use of DECIdE with the healthcare professional for this situation * Agreeing to take part in the study and to sign the written consent form * Speaks and understands French Exclusion Criteria: * minor patients * Patients under guardianship, curatorship or safeguard of justice * Pregnant or breast-feeding women * Second use of the DECIdE tool in the same situation / for the same drug * Refusal to take part in the study * Patient not affiliated to a medical insurance
Contact & Investigator
Hélène Vaillant-Roussel, PhD
PRINCIPAL INVESTIGATOR
University Hospital, Clermont-Ferrand
Frequently Asked Questions
Who can join the NCT06052917 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Decision Making, Shared. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06052917 currently recruiting?
Yes, NCT06052917 is actively recruiting participants. Contact the research team at promo_interne_drci@chu-clermontferrand.fr for enrollment information.
Where is the NCT06052917 trial being conducted?
This trial is being conducted at Clermont-Ferrand, France, Grenoble, France, Lyon, France, Saint-Etienne, France.
Who is sponsoring the NCT06052917 clinical trial?
NCT06052917 is sponsored by University Hospital, Clermont-Ferrand. The principal investigator is Hélène Vaillant-Roussel, PhD at University Hospital, Clermont-Ferrand. The trial plans to enroll 288 participants.